Annu. Rev. Pharmacol. Toxicol. 1979.19:469-490. Downloaded from www.annualreviews.org by University of Minnesota - Twin Cities on 09/06/13. For personal use only.
NONSTEROIDAL
.6750
ANTI-INFLAMMATORY AGENTS Rodney Nickander Department of Immunology and Connective Tissue Research, The Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana
46206
F. Gilbert McMahon Department of Medicine, Tulane
1430
University
School of Medicine,
Tulane Avenue, New Orleans, Louisiana
70112
Anthony S. Ridoifo Clinical Research Division, The Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana
46206
INTRODUCTION
Nonsteroidal anti-inflammatory agents (NSAIA) have as their major phar macological effect the reduction of edema, erythema, and resulting tissue damage associated with inflammatory conditions, but many also share the actions of analgesia and antipyresis. This triad of action-anti-inflamma tory, analgesic, and antipyretic-